TY  - GEN
AU  - Beltrand,Jacques
AU  - Elie,Caroline
AU  - Busiah,Kanetee
AU  - Fournier,Emmanuel
AU  - Boddaert,Nathalie
AU  - Bahi-Buisson,Nadia
AU  - Vera,Miriam
AU  - Bui-Quoc,Emmanuel
AU  - Ingster-Moati,Isabelle
AU  - Berdugo,Marianne
AU  - Simon,Albane
AU  - Gozalo,Claire
AU  - Djerada,Zoubir
AU  - Flechtner,Isabelle
AU  - Treluyer,Jean-Marc
AU  - Scharfmann,Raphael
AU  - Cavé,Helene
AU  - Vaivre-Douret,Laurence
AU  - Polak,Michel
TI  - Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations
SN  - 1935-5548
PY  - 2016///0606
KW  - Administration, Oral
KW  - Adolescent
KW  - Brain
KW  - pathology
KW  - Child
KW  - Child, Preschool
KW  - Diabetes Mellitus
KW  - drug therapy
KW  - Drug Substitution
KW  - Female
KW  - Glyburide
KW  - administration & dosage
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Infant
KW  - Infant, Newborn
KW  - Insulin
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Mutation
KW  - Neurologic Manifestations
KW  - Neuropsychological Tests
KW  - Potassium Channels, Inwardly Rectifying
KW  - genetics
KW  - Psychomotor Performance
KW  - Sulfonylurea Receptors
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.2337/dc15-0837
ER  -